Medexus Pharmaceuticals (MEDXF) Earnings Date & Reports
Medexus Pharmaceuticals Inc is a specialty pharmaceutical company with a powerful North American commercial platform and a growing portfolio of inventive and rare disease treatment solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MEDXF is expected to report earnings to fall 97.00% to 0 cents per share on February 11
Q4'25
Est.
$0.00
Q3'25
Est.
$-0.01
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.05
The last earnings report on November 12 showed earnings per share of 0 cents, beating the estimate of -1 cents. With 16.55K shares outstanding, the current market capitalization sits at 61.41M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MEDXF showed earnings on November 12, 2025. You can read more about the earnings report here.